Vaccines segment

Dynavax Technologies Corporation - Common Stock

1.58% down 9.55% -7.97

+ Immunology, Biology, Biopharma, Medicine, Vaccines

Last highlighted: #DVAX SEC report: DYNAVAX TECHNOLOGIES CORP Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by DYNAVAX TECHNOLOGIES CORP -- SEC File Number

+ My List

We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.